Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Rodig

Showing results (191-200 of 293) with videos related to

Pageof 30
Sort By:
Nature Communications|July 7, 2023
Expanded vacuum-stable gels for multiplexed high-resolution spatial histopathologyYunhao Bai, Bokai Zhu, John-Paul Oliveria, et al.
Nature Communications|March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trialRebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2018
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell CarcinomaJonathan D Schoenfeld, Evisa Gjini, Scott J Rodig, et al.
Cancer Discovery|May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantationOliver Weigert, Nadja Kopp, Andrew A Lane, et al.
British Journal of Haematology|October 7, 2016
Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphomaAlex F Herrera, Haesook T Kim, Katherine A Kong, et al.
The New England Journal of Medicine|October 29, 2010
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumorJames E Butrynski, David R D'Adamo, Jason L Hornick, et al.
Oncotarget|January 23, 2015
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaZiming Du, Malak Abedalthagafi, Ayal A Aizer, et al.
Blood|May 27, 2021
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucelVicki Plaks, John M Rossi, Justin Chou, et al.
Cancer Immunology Research|April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma PatientsF Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
JCO Precision Oncology|May 13, 2020
P2RY8-CRLF2Fusion-Positive Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Response to Novel TherapyUmut Aypar, Justin Taylor, Jacqueline S Garcia, et al.
Pageof 30

Showing results (191-200 of 293) with videos related to

Sort By:
Pageof 30
Nature Communications|July 7, 2023
Expanded vacuum-stable gels for multiplexed high-resolution spatial histopathologyYunhao Bai, Bokai Zhu, John-Paul Oliveria, et al.
Nature Communications|March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trialRebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2018
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell CarcinomaJonathan D Schoenfeld, Evisa Gjini, Scott J Rodig, et al.
Cancer Discovery|May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantationOliver Weigert, Nadja Kopp, Andrew A Lane, et al.
British Journal of Haematology|October 7, 2016
Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphomaAlex F Herrera, Haesook T Kim, Katherine A Kong, et al.
The New England Journal of Medicine|October 29, 2010
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumorJames E Butrynski, David R D'Adamo, Jason L Hornick, et al.
Oncotarget|January 23, 2015
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaZiming Du, Malak Abedalthagafi, Ayal A Aizer, et al.
Blood|May 27, 2021
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucelVicki Plaks, John M Rossi, Justin Chou, et al.
Cancer Immunology Research|April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma PatientsF Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
JCO Precision Oncology|May 13, 2020
P2RY8-CRLF2Fusion-Positive Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Response to Novel TherapyUmut Aypar, Justin Taylor, Jacqueline S Garcia, et al.
Pageof 30